Senate antitrust subcommittee health care agenda
Executive Summary
Rx industry competition issues will be examined by Senate Judiciary/Antitrust, Competition Policy & Consumer Rights Subcommittee in 2003, subcommittee Chairman Mike DeWine (R-Ohio) announces. Committee will focus on "the state of competition in the prescription drug industry to ensure that consumers benefit from vigorous competition in the prescription drug market," agenda says. Subcommittee also plans continued inquiry into group purchasing organizations' "reforms to their business practices" (1"The Pink Sheet" May 13, 2002, p. 18)...
You may also be interested in...
GPO Self-Regulation Prescribed As Alternative To Congressional Action
GPO conflicts-of-interest will be one topic addressed by a group purchasing organization working group formed at the behest of Senate Judiciary/Antitrust Subcommittee Chairman Herbert Kohl (D-Wisc.)
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.